Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approach

A new semisynthetic derivative of the natural alkaloid, theobromine, has been designed as a lead antiangiogenic compound targeting the EGFR protein. The designed compound is an (m-tolyl)acetamide theobromine derivative, (T-1-MTA). Molecular Docking studies have shown a great potential for T-1-MTA to...

Descripción completa

Detalles Bibliográficos
Autores principales: Eissa, Ibrahim H., Yousef, Reda G., Elkaeed, Eslam B., Alsfouk, Aisha A., Husein, Dalal Z., Ibrahim, Ibrahim M., Alesawy, Mohamed S., Elkady, Hazem, Metwaly, Ahmed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997933/
https://www.ncbi.nlm.nih.gov/pubmed/36893122
http://dx.doi.org/10.1371/journal.pone.0282586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997933/
https://www.ncbi.nlm.nih.gov/pubmed/36893122
http://dx.doi.org/10.1371/journal.pone.0282586

Ejemplares similares